West Pharmaceutical Services Long Term Debt 2010-2024 | WST

West Pharmaceutical Services long term debt for the quarter ending December 31, 2024 was $0.203B, a 178.3% increase year-over-year.

  • West Pharmaceutical Services long term debt for 2024 was $0.203B, a 178.3% increase from 2023.
  • West Pharmaceutical Services long term debt for 2023 was $0.073B, a 64.78% decline from 2022.
  • West Pharmaceutical Services long term debt for 2022 was $0.207B, a 1.01% decline from 2021.
Related Stocks
Company NameMarket
Cap
McKesson (MCK)$87.4B
Becton Dickinson (BDX)$57.1B
Cardinal Health (CAH)$32.5B
Straumann Holding AG (SAUHY)$18.7B
Labcorp (LH)$18.2B
Cooper (COO)$15.9B
Align Technology (ALGN)$12.5B
Henry Schein (HSIC)$7.9B
Merit Medical Systems (MMSI)$5.4B
Patterson (PDCO)$2.8B
DENTSPLY SIRONA (XRAY)$2.6B
CONMED (CNMD)$1.5B
STAAR Surgical (STAA)$833M
Pro-Dex (PDEX)$198M
Lifevantage (LFVN)$169M